Issues And Trends In Healthcare Delivery System
Prescription, Nonprescription and Orphan Drugs
Standards of Care I
Drug Products: Biologics, Biosimilars and Interchangeables
Healthcare Agencies II
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 28, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Pragya Kakani1,2,3, Jessica Lu4, Dima Mazen Qato5,6
1Division of Health Policy and Economics, Joan and Sanford I. Weill Medical College, Cornell University, New York, New York.
No abstract available in PubMed .